Physician profile
Justin Ford
NPI 1275746026
$1,176.82
in general payments reported to CMS, 2019-2025
17 companies · $429 in 2025
The $429 reported for 2025 was less than what a typical Pain Medicine (Anesthesiology) provider received nationally (typical 2025 total: $458).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $81.70 · 2020: $33.02 · 2021: $127 · 2022: $302 · 2023: $129 · 2024: $74.74 · 2025: $429.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $633.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $633.37 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $252.42 | 2020-2025 | General - Pain Management |
| Medtronic, INC. | $221.45 | 2021-2025 | Inceptiv |
| Abbvie INC. | $158.84 | 2019-2024 | |
| Averitas Pharma INC. | $109.89 | 2025 | Qutenza |
| Avanos Medical | $61.98 | 2024-2025 | Standard Rf Disposables |
| Abbott Laboratories | $54.31 | 2021 | |
| Virtus Pharmaceuticals LLC | $50.20 | 2025 | Levorphanol Tartrate |
| Globus Medical, INC. | $42.58 | 2025 | Senza |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $38.44 | 2019-2025 | Relistor |
| Collegium Pharmaceutical, INC. | $37.30 | 2021-2025 | Belbuca |
| Pfizer INC. | $28.15 | 2019 | |
| Vertex Pharmaceuticals Incorporated | $26.64 | 2025 | |
| Mdd US Operations, LLC | $21.86 | 2019 | |
| Ibsa Pharma INC. | $20.49 | 2023 | Tirosint, Licart |
| Allergan, INC. | $20.11 | 2020 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Valinor Pharma, LLC | $16.98 | 2025 | Movantik |
| Forte Bio-Pharma LLC | $15.18 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Justin Ford listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.